Lysophosphatidylcholine as a ligand for immunoregulation (Q46889699)

26 December 2017

title

Lysophosphatidylcholine as a ligand for immunoregulation (English)

1 reference

26 December 2017

author name string

Janusz H S Kabarowski

series ordinal

1

1 reference

26 December 2017

Yan Xu

series ordinal

2

1 reference

26 December 2017

Owen N Witte

series ordinal

3

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

26 December 2017

published in

Biochemical Pharmacology

1 reference

26 December 2017

volume

64

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

161-167

1 reference

26 December 2017

Lysophospholipid receptors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophospholipids--receptor revelations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Phospholipase A2 enzymes in eicosanoid generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Immunology. The push-me pull-you of T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Direct genetic demonstration of G alpha 13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

G2A is an oncogenic G protein-coupled receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Isolation of three novel human genes encoding G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Identification of a molecular target of psychosine and its role in globoid cell formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidic acids produced by lysophospholipase D in mammalian serum and body fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Genetics of systemic lupus erythematosus. Clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Toll receptors in innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

The induction of tolerance by dendritic cells that have captured apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Oxidative stress as a mediator of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Death receptors: signaling and modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Apoptosis and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Involvement of Protein Kinase C–Independent Mechanisms in Endothelial ICAM‐1 Up‐regulation by Lysophosphatidylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901179-6

10.1016/S0006-2952(02)01179-6

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017